Cor Vasa 2014, 56(4):e333-e336 | DOI: 10.1016/j.crvasa.2014.04.002

The magnitude of percutaneous coronary intervention treatment in high and medium risk non-ST elevation acute coronary syndrome

David Becker*, Anna Móri, Gyorgy Bárczi, Hajnalka Vágó, Orsolya Szenczi, Balazs Berta, Krisztina Heltai, Endre Zima, Pal Maurovich-H., Bela Merkely
Semmelweis University Heart and Vascular Center, Budapest, Hungary

Introduction: Current ESC guideline supported invasive treatment of non-ST elevation acute coronary syndrome (NSTE-ACS) is guided by GRACE risk model.

Objective: The aim of this study was to determine whether the percutaneous coronary intervention treatment in NSTE-ACS ameliorates the long-term mortality assessed by GRACE risk score.

Methods: We conducted a retrospective study of a consecutive sample of 680 patients with NSTE-ACS treated by PCI in Heart Center of Semmelweis University. The GRACE risk score was calculated for each patient at admission. The mean of relative risk in each group was assessed and compared with the long-term clinical outcomes (observed 6-month mortality).

Results: The mean of calculated GRACE amounts 1.6% for low risk patients, 5.0% for medium risk patients, and 21.3% for patients with high risk. In contrast, the observed risk of 6-month death was 0.42% for low risk patients, 1.1% for medium risk patients, and 12.6% for patients with high risk.
Difference between assessed and observed 6-month mortality in high risk and medium risk groups was significant (medium risk p = 0.004; high risk p = 0.0097). Observed risk of death in low risk patients was also lower, but not significant than assessed risk.

Conclusion: The risk of death in patients with NSTE-ACS treated in high volume center is significantly lower than predicted by GRACE risk model. Our results suggest that percutaneous coronary intervention treatment guided by GRACE risk model in medium and high risk patents with NSTE-ACS provides the greatest clinical benefit.

Keywords: Acute coronary syndrome; GRACE; Percutaneous coronary intervention

Received: February 27, 2014; Revised: April 6, 2014; Accepted: April 8, 2014; Published: August 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Becker D, Móri A, Bárczi G, Vágó H, Szenczi O, Berta B, et al.. The magnitude of percutaneous coronary intervention treatment in high and medium risk non-ST elevation acute coronary syndrome. Cor Vasa. 2014;56(4):e333-336. doi: 10.1016/j.crvasa.2014.04.002.
Download citation

References

  1. W. Rosamond, K. Flegal, K. Furie, et al., Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation 117 (2008) e25-e146. Go to original source... Go to PubMed...
  2. C.W. Hamm, J.P. Bassand, S. Agewall, et al., ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), European Heart Journal 32 (2011) 2999-3054.
  3. A. Filippi, G. D'Ambrosio, S.E. Giustini, et al., Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care, Journal of Cardiovascular Medicine 10 (2009) 714-718. Go to original source... Go to PubMed...
  4. F. Giallauria, R. Lucci, M. D'Agostino, et al., Two-year multicomprehensive secondary prevention program: favorable effects on cardiovascular functional capacity and coronary risk profile after acute myocardial infarction, Journal of Cardiovascular Medicine 10 (2009) 772-780. Go to original source... Go to PubMed...
  5. L.A. Allen, C.J. O'Donnell, C.A. Camargo Jr., et al., Comparison of long-term mortality across the spectrum of acute coronary syndromes, American Heart Journal 151 (2006) 1065-1071. Go to original source... Go to PubMed...
  6. J.D. Abbott, H.N. Ahmed, H.A. Vlachos, et al., Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry), American Journal of Cardiology 100 (2007) 190-195. Go to original source... Go to PubMed...
  7. O.M. Jolobe, Guidelines for the diagnosis and treatment of non-ST segment elevation acute coronary syndromes, European Heart Journal 29 (2008) 277. Go to original source...
  8. G. Montalescot, J. Dallongeville, E. Van Belle, et al., STEMI and NSTEMI: are they so different? 1 Year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry), European Heart Journal 28 (2007) 1409-1417. Go to original source...
  9. K.A. Fox, K.F. Carruthers, D.R. Dunbar, et al., Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study), European Heart Journal 31 (2010) 2755-2764. Go to original source... Go to PubMed...
  10. P. Tousek, F. Tousek, D. Horak, et al., The incidence and outcomes of acute coronary syndromes in a central European country: results of the CZECH-2 registry, International Journal of Cardiology 173 (2014) 204-208. Go to original source... Go to PubMed...
  11. K.A. Fox, O.H. Dabbous, R.J. Goldberg, et al., Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE), British Medical Journal 333 (2006) 1091. Go to original source... Go to PubMed...
  12. J. Kowalczyk, R. Lenarczyk, K. Strojek, et al., Prognosis in diabetic patients with acute myocardial infarction treated invasively is related to renal function, Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 16 (2010) CR67-CR74.
  13. P. Perrone-Filardi, L. Pace, S. Dellegrottaglie, et al., Rest-redistribution 201-Thallium single photon emission computed tomography predicts myocardial infarction and cardiac death in patients with ischemic left ventricular dysfunction, Journal of Cardiovascular Medicine 10 (2009) 122-128. Go to original source... Go to PubMed...
  14. K.E. Hammermeister, T.A. DeRouen, H.T. Dodge, Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations, Circulation 59 (1979) 421-430. Go to original source... Go to PubMed...
  15. D. Hasdai, S. Behar, V. Boyko, et al., Cardiac biomarkers and acute coronary syndromes-the Euro Heart Survey of Acute Coronary Syndromes Experience, European Heart Journal 24 (2003) 1189-1194. Go to original source... Go to PubMed...
  16. D. Hasdai, A. Porter, A. Rosengren, et al., Effect of gender on outcomes of acute coronary syndromes, American Journal of Cardiology 91 (1466-1469) (2003) A1466. Go to original source... Go to PubMed...
  17. O. Manfrini, R. Bugiardini, Barriers to clinical risk scores adoption, European Heart Journal 28 (2007) 1045-1046. Go to original source... Go to PubMed...
  18. R. Spacek, P. Widimsky, Z. Straka, et al., Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study, European Heart Journal 23 (2002) 230-238. Go to original source... Go to PubMed...
  19. P. Widimsky, W. Wijns, Z. Kaifoszova, Stent for Life: how this initiative began?, EuroIntervention 8 (Suppl. P) (2012) P8-P10. Go to original source... Go to PubMed...
  20. A. Alonso, J.M. Gore, H.H. Awad, et al., Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registry, European Heart Journal. Acute Cardiovascular Care 2 (2013) 280-291. Go to original source... Go to PubMed...
  21. K.A. Fox, S.G. Goodman, F.A. Anderson Jr., et al., From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE), European Heart Journal 24 (2003) 1414-1424. Go to original source... Go to PubMed...
  22. R.J. Goldberg, P.G. Steg, I. Sadiq, et al., Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry), American Journal of Cardiology 89 (2002) 791-796. Go to original source... Go to PubMed...
  23. S.G. Goodman, P.G. Steg, K.A. Eagle, et al., The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE), American Heart Journal 151 (2006) 654-660. Go to original source... Go to PubMed...
  24. C.B. Granger, Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry, American Journal of Cardiology 86 (2000) 4M-9M. Go to original source... Go to PubMed...
  25. A.T. Yan, R.T. Yan, M. Tan, et al., In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score, American Journal of Cardiology 96 (2005) 913-916. Go to original source... Go to PubMed...
  26. R.S. Wright, J.L. Anderson, C.D. Adams, et al., 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons, Journal of the American College of Cardiology 57 (2011) 1920-1959. Go to original source... Go to PubMed...
  27. A.T. Yan, R.T. Yan, M. Tan, et al., Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better, European Heart Journal 28 (2007) 1072-1078. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.